• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil.

作者信息

Florentino Pilar T V, Alves Flávia J O, Cerqueira-Silva Thiago, de Araújo Oliveira Vinicius, Júnior Juracy B S, Penna Gerson O, Boaventura Viviane, Werneck Guilherme L, Pearce Neil, Rodrigues Laura C, Barreto Mauricio L, Barral-Netto Manoel, Paixão Enny S

机构信息

Centre of Data and Knowledge Integration for Health, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil; Biomedical Science Institute, University of São Paulo, São Paulo, 41745-715 Brazil.

Centre of Data and Knowledge Integration for Health, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.

出版信息

Lancet Infect Dis. 2022 Dec;22(12):1669-1670. doi: 10.1016/S1473-3099(22)00728-9. Epub 2022 Nov 7.

DOI:10.1016/S1473-3099(22)00728-9
PMID:36356609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9640198/
Abstract
摘要

相似文献

1
Effectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil.在巴西奥密克戎时期，BNT162b2加强针在接种科兴疫苗初免方案后的孕妇中的有效性。
Lancet Infect Dis. 2022 Dec;22(12):1669-1670. doi: 10.1016/S1473-3099(22)00728-9. Epub 2022 Nov 7.
2
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.在巴西（Immunita-001）进行的一项为期一年的 4 期研究：两剂基础免疫方案接种灭活病毒（科兴疫苗）和 BNT162b2 异源加强针的免疫原性、有效性和安全性。
Front Immunol. 2022 Jun 9;13:918896. doi: 10.3389/fimmu.2022.918896. eCollection 2022.
3
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection.同源和异源 BNT162b2、CoronaVac 和 AZD1222 加强疫苗对 Delta 和奥密克戎 SARS-CoV-2 感染的真实世界有效性。
Emerg Microbes Infect. 2022 Dec;11(1):1343-1345. doi: 10.1080/22221751.2022.2072773.
4
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率：哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
5
SARS-CoV-2 specific antibody responses in healthcare workers after a third booster dose of CoronaVac or BNT162b2 vaccine.第三剂科兴或辉瑞疫苗加强针后医护人员针对 SARS-CoV-2 的抗体反应。
J Med Virol. 2022 Aug;94(8):3768-3775. doi: 10.1002/jmv.27794. Epub 2022 Apr 23.
6
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies.智利科兴疫苗和加强针的血清学研究：抗 SARS-CoV-2 刺突抗体的免疫原性和持久性。
BMC Med. 2022 Jun 9;20(1):216. doi: 10.1186/s12916-022-02406-0.
7
Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine.CoronaVac 加强针接种后对 SARS-CoV-2 抗体反应的动力学。
Emerg Infect Dis. 2022 Jun;28(6):1237-1240. doi: 10.3201/eid2806.220061. Epub 2022 Apr 14.
8
Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study.疫苗加强针、疫苗类型以及混合免疫对合并症老年人中针对 SARS-CoV-2 原始株和奥密克戎变异株亚谱系 BA.2 和 BA.5 的体液和细胞免疫的影响：一项横断面研究。
EBioMedicine. 2023 Feb;88:104446. doi: 10.1016/j.ebiom.2023.104446. Epub 2023 Jan 25.
9
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.同源和异源加强针对于灭活 SARS-CoV-2 疫苗的有效性：一项大规模前瞻性队列研究。
Lancet Glob Health. 2022 Jun;10(6):e798-e806. doi: 10.1016/S2214-109X(22)00112-7. Epub 2022 Apr 23.
10
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients.BNT162b2 或科兴疫苗接种者血清对严重急性呼吸综合征冠状病毒 2 奥密克戎变异株的中和作用。
Clin Infect Dis. 2022 Aug 24;75(1):e822-e826. doi: 10.1093/cid/ciab1041.

引用本文的文献

1
Text mining method to unravel long COVID's clinical condition in hospitalized patients.文本挖掘方法揭示住院患者长新冠的临床状况。
Cell Death Dis. 2024 Sep 13;15(9):671. doi: 10.1038/s41419-024-07043-4.
2
Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis.妊娠期 COVID-19 疫苗的安全性和有效性：一项实时系统评价和荟萃分析。
Drug Saf. 2024 Oct;47(10):991-1010. doi: 10.1007/s40264-024-01458-w. Epub 2024 Jul 15.
3
Safety of BNT162b2 and CoronaVac during pregnancy on birth outcomes and neonatal mortality: a cohort study from Brazil.孕期接种 BNT162b2 和科兴疫苗对出生结局和新生儿死亡率的安全性：来自巴西的队列研究。
Int J Epidemiol. 2023 Dec 25;52(6):1708-1715. doi: 10.1093/ije/dyad120.

本文引用的文献

1
Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel.孕期接种第三剂 BNT162b2 mRNA COVID-19 疫苗的有效性：以色列的一项全国性观察性研究。
Nat Commun. 2022 Nov 15;13(1):6961. doi: 10.1038/s41467-022-34605-x.
2
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States.美国 Delta 和奥密克戎变异株流行期间估计 COVID-19 mRNA 疫苗在孕妇中对有医疗需要的 COVID-19 的有效性。
JAMA Netw Open. 2022 Sep 1;5(9):e2233273. doi: 10.1001/jamanetworkopen.2022.33273.
3
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil.科兴疫苗加强针与辉瑞-BioNTech 异源疫苗对奥密克戎变异株的保护效力持续时间：巴西研究
Nat Commun. 2022 Jul 18;13(1):4154. doi: 10.1038/s41467-022-31839-7.
4
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.mRNA 疫苗对 COVID-19 相关急诊科和紧急护理就诊以及成人住院的 2 剂和 3 剂效力下降在德尔塔和奥密克戎变异主导期间 - VISION 网络，10 个州，2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):255-263. doi: 10.15585/mmwr.mm7107e2.
5
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.奥密克戎能广泛但不完全地逃避辉瑞 BNT162b2 的中和作用。
Nature. 2022 Feb;602(7898):654-656. doi: 10.1038/s41586-021-04387-1. Epub 2021 Dec 23.
6
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.两剂 ChAdOx1 nCoV-19 疫苗对 COVID-19 住院和死亡的保护作用随时间变化的回顾性、基于人群的队列研究：苏格兰和巴西的研究。
Lancet. 2022 Jan 1;399(10319):25-35. doi: 10.1016/S0140-6736(21)02754-9. Epub 2021 Dec 20.
7
A Test-Negative Design with Additional Population Controls Can Be Used to Rapidly Study Causes of the SARS-CoV-2 Epidemic.采用附加人群对照的阴性病例设计可用于快速研究导致 SARS-CoV-2 流行的原因。
Epidemiology. 2020 Nov;31(6):836-843. doi: 10.1097/EDE.0000000000001251.